Abstract
Identification of immune-mediated neuropathies is important as these disorders often respond to treatment. Patterns of binding of serum M (mononclonal) proteins and autoantibodies correlate with, and may be diagnostic markers for, specific polyneuropathy syndromes. There is evidence that some of these antibodies may play a pathogenic role in polyneuropathy syndromes. Identification of specific immune polyneuropathy syndromes provides guidance regarding immunosuppressive regimens that may be effective treatments.
| Original language | English |
|---|---|
| Pages (from-to) | 681-687 |
| Number of pages | 7 |
| Journal | Current opinion in neurology |
| Volume | 6 |
| Issue number | 5 |
| DOIs | |
| State | Published - Jan 1 1993 |